These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 37576865)

  • 1. YAP/TAZ: Molecular pathway and disease therapy.
    Wei Y; Hui VLZ; Chen Y; Han R; Han X; Guo Y
    MedComm (2020); 2023 Aug; 4(4):e340. PubMed ID: 37576865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK/FOXO1 axis.
    Mohseni R; Alavian SM; Sadeghabadi ZA; Heiat M
    Mol Biol Rep; 2021 Jan; 48(1):117-126. PubMed ID: 33296068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
    Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK
    Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases.
    Yu Y; Su X; Qin Q; Hou Y; Zhang X; Zhang H; Jia M; Chen Y
    Pharmacol Res; 2020 Sep; 159():105009. PubMed ID: 32553712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippo-YAP/TAZ Signaling Pathway in Intestinal Self-Renewal and Regeneration After Injury.
    Deng F; Wu Z; Zou F; Wang S; Wang X
    Front Cell Dev Biol; 2022; 10():894737. PubMed ID: 35927987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis.
    Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D
    Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.
    Wang Y; Chen H; Yu J; Kang W; To KF
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188787. PubMed ID: 36041574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between YAP/TAZ and Metabolism.
    Koo JH; Guan KL
    Cell Metab; 2018 Aug; 28(2):196-206. PubMed ID: 30089241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.
    Ortega Á; Vera I; Diaz MP; Navarro C; Rojas M; Torres W; Parra H; Salazar J; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
    Strepkos D; Markouli M; Papavassiliou KA; Papavassiliou AG; Piperi C
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12762. PubMed ID: 34409639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yap/Taz Deletion in Gli
    Liang M; Yu M; Xia R; Song K; Wang J; Luo J; Chen G; Cheng J
    J Am Soc Nephrol; 2017 Nov; 28(11):3278-3290. PubMed ID: 28768710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.